Sotera Health Company
SHC
$17.70
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.15B | 1.12B | 1.11B | 1.10B | 1.12B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.15B | 1.12B | 1.11B | 1.10B | 1.12B |
| Cost of Revenue | 506.40M | 500.09M | 496.18M | 498.15M | 502.46M |
| Gross Profit | 643.98M | 624.44M | 610.61M | 602.30M | 618.01M |
| SG&A Expenses | 200.98M | 202.68M | 200.82M | 202.13M | 199.67M |
| Depreciation & Amortization | 43.10M | 55.52M | 61.63M | 62.04M | 62.36M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 750.47M | 758.29M | 758.63M | 762.32M | 764.50M |
| Operating Income | 399.91M | 366.25M | 348.16M | 338.13M | 355.98M |
| Income Before Tax | 121.97M | 91.79M | 88.04M | 113.87M | 134.58M |
| Income Tax Expenses | 66.55M | 67.77M | 63.22M | 69.48M | 63.82M |
| Earnings from Continuing Operations | 55.43 | 24.02 | 24.82 | 44.40 | 70.76 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 55.43M | 24.02M | 24.82M | 44.40M | 70.76M |
| EBIT | 399.91M | 366.25M | 348.16M | 338.13M | 355.98M |
| EBITDA | 546.86M | 527.94M | 514.74M | 504.40M | 522.67M |
| EPS Basic | 0.20 | 0.08 | 0.09 | 0.16 | 0.25 |
| Normalized Basic EPS | 0.52 | 0.44 | 0.40 | 0.38 | 0.42 |
| EPS Diluted | 0.19 | 0.08 | 0.08 | 0.15 | 0.25 |
| Normalized Diluted EPS | 0.52 | 0.44 | 0.40 | 0.37 | 0.42 |
| Average Basic Shares Outstanding | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B |
| Average Diluted Shares Outstanding | 1.14B | 1.14B | 1.14B | 1.14B | 1.14B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |